<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>terapötik stratejiler &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/terapotik-stratejiler/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 01 Dec 2025 09:23:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>terapötik stratejiler &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>β-Catenin Drives Peritoneal Fibrosis via Mitochondrial Fission</title>
		<link>https://bioengineer.org/%ce%b2-catenin-drives-peritoneal-fibrosis-via-mitochondrial-fission/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 01 Dec 2025 09:23:02 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[mezotelyal hücreler]]></category>
		<category><![CDATA[mitokondriyal füzyon]]></category>
		<category><![CDATA[peritoneal fibroz]]></category>
		<category><![CDATA[terapötik stratejiler]]></category>
		<category><![CDATA[β-katenin]]></category>
		<guid isPermaLink="false">https://bioengineer.org/%ce%b2-catenin-drives-peritoneal-fibrosis-via-mitochondrial-fission/</guid>

					<description><![CDATA[Recent advancements in the field of medical research have illuminated the multifaceted role of β-catenin in peritoneal fibrosis, a condition marked by the thickening and scarring of the peritoneum. The phenomenon of fibrosis can have disastrous implications for patients, leading not only to discomfort but also to significant complications in renal treatment processes, particularly in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303870</post-id>	</item>
	</channel>
</rss>
